IMPAIRED GLUCOSE EFFECTIVENESS IN PATIENTS WITH POLYCYSTIC-OVARY-SYNDROME

被引:18
作者
FALCONE, T [1 ]
LITTLE, AB [1 ]
MORRIS, D [1 ]
机构
[1] ROYAL VICTORIA HOSP,DEPT MED,687 PINE AVE W,MONTREAL H3A 1A1,QUEBEC,CANADA
关键词
GLUCOSE EFFECTIVENESS (SG); INSULIN SENSITIVITY (SI);
D O I
10.1093/oxfordjournals.humrep.a137771
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Insulin resistance and glucose intolerance are common features of polycystic ovary syndrome (PCOS). We have investigated the effect of glucose on the fractional glucose disappearance in patients with PCOS and in age- and weight-matched control subjects. The minimal model method as applied to a frequently sampled intravenous glucose tolerance test was employed. The insulin sensitivity index (S(i)) and glucose effectiveness (SG) were calculated with the MINMOD program. Testosterone, androstenedione and free testosterone concentrations were significantly higher in PCOS subjects. Glucose-induced glucose clearance (SG) and insulin sensitivity were significantly lower in PCOS subjects than controls [SG: 2.7 +/- 0.3 versus 1.8 +/- 0.1 x 100/min; P < 0.01; S(i): 133.4 +/- 20.0 versus 65.6 +/- 6.4/min (nmol/ml)]. Six PCOS women had an SG value within the normal range (> 2.0 x 100/min) but had a similar S(i) to that found in PCOS women with abnormal SG. We suggest that independent alterations in both glucose- and insulin-mediated glucose uptake occur in patients with PCOS. The underlying disturbance in glucose effectiveness may be similar to that found in familial non-insulin dependent diabetes mellitus.
引用
收藏
页码:922 / 925
页数:4
相关论文
共 13 条
[1]  
Berman R.N., Prager R., Volund A., Olefsky J.M., Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic clamp, J. Clin. Invest, 79, pp. 790-800, (1987)
[2]  
Dunaif A., Segal K., Futterwert W., Dobijansky J., Profound peripheral resistance independent of obesity in polycystic ovary syndrome, Diabetes, 38, pp. 1165-1174, (1989)
[3]  
Falcone T., Finegood D.T., Fantus J.G., Morris D., Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogénie women, J. Clin. Endocrinol. Metab, 71, pp. 1653-1657, (1990)
[4]  
Fantus I.G., Brosseau N., Mechanism of action of metformin: Insulin receptor and post receptor effects in vitro and in vivo, J. Clin. Endocrinol. Metab, 63, pp. 898-905, (1980)
[5]  
Femman D., Human Hair Growth in Health and Disease, (1971)
[6]  
Garvey W.T., Olefsky J.M., Marshall S., Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites, Diabetes, 25, (1986)
[7]  
Moller D.E., Flier J.S., Detection of an alteration in the insulin receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome, N. Engl. J. Med, 31, pp. 1526-1529, (1988)
[8]  
New M.I., Lorenzen F., Lemer A.J., Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data, J. Clin. Endocrinol, pp. 320-326, (1983)
[9]  
Pacini G., Bergman R.N., MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Compta, Methods Progr. Biomed, 23, pp. 113-122, (1986)
[10]  
Peiris A.N., Aiman E.J., Drucker W.D., Kissebah A.H., The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogénie women, J. Clin. Endocrinol. Metab, 68, pp. 715-720, (1989)